WASHINGTON, June 30, 2005 (PRIMEZONE) -- Nuclear Solutions, Inc. (OTCBB:NSOL) announced today that the second of its pending patent applications for a new process to remediate tritiated water was granted clearance by the U.S. government for foreign filing after an extensive level three national security review.
Previously, the company reported that it received clearance from the U.S. government for foreign filing of its initial patent application for its new tritiated water clean-up technology, and subsequently filed its first international patent application in June 2005.
"I am happy to report that our second patent application for our tritium contaminated water remediation technology was granted foreign filing clearance. This is yet another positive development critical to our commercialization efforts, and further opens up the opportunity for us to apply for intellectual property protection in multiple counties, thus expanding the potential market for our technology.
"Overall, June was a good month for us on the intellectual property front, and to top it off we received the check for the balance of the quarterly license fee due to us from IPTH," said, Patrick Herda, CEO of Nuclear Solutions.
The company previously reported that a level three national security review is the highest-level security review for a patent application. The process involves the U.S. Patent office distributing the patent application to multiple United States government agencies. When all agencies have determined that the foreign filing of the subject patent would not compromise U.S. national security interests, foreign filing clearance is granted.
Tritium, a radioactive isotope, has a half-life of only 12.3 years, but its presence in wastewater poses a significant health risk because it is absorbed into environmental systems like ordinary water. Large quantities of tritium are produced as a byproduct of nuclear power plant operations and nuclear weapons complex activities. The ingestion of tritiated water can result in radiation-induced damage to chromosomes within cell nuclei. While researchers differ about the relative dangers of exposure to high levels of tritium, several studies have linked high tritium discharges to cancers and birth deformities.
About Nuclear Solutions, Inc.:
Nuclear Solutions, based in Washington, D.C., is an emerging innovative technology development company. We are committed to exploring, developing, and commercializing viable product technologies that will enable partner companies to offer new and improved products in the following areas:
Nuclear Weapon Detection for Homeland Security & Defense
The development of advanced technology to detect shielded nuclear materials and terrorist nuclear weapons.
Nanotechnology/MEMS applications
The development of long-lived nuclear micro-power sources, based on three U.S. Patents (5,087,533; 6,118,204; 6,238,812), to power applications in the emerging field of Nanotechnology, Micro-Electro-Mechanical Systems, and the new generation of low power microelectronics.
Environmental Technology
Development of a patent pending process to remediate tritiated water via an advanced separation technique.
More information about Nuclear Solutions, Inc. may be found on its website, www.nuclearsolutions.com.
Disclaimer: The matters discussed in this press release are forward-looking statements that involve a number of risks and uncertainties such as our plans, objective, expectations and intentions. You can identify these statements by our use of words such as "may," "when," "expect," "believe," "anticipate," "intend," "could," "estimate," "continue," "plans," "planning," "potentially," "would," or other similar words or phrases. Some of these statements include discussions regarding our future business strategy and our ability to generate revenue, income, and cash flow. Additional funding is required to develop the technology described herein. The actual future results for the Company could differ significantly from those statements. Factors that could adversely affect actual results and performance include, among others, the Company's limited operating history, dependence on key management, financing requirements, technical difficulties commercializing any projects, government regulation, technological change, and competition. In any event, undue reliance should not be placed on any forward-looking statements, which apply only as of the date of this press release. Additionally, patent pending status does not guarantee that a patent will issue or that the technology will be commercially successful. Accordingly, reference should be made to the Company's periodic filings with the U.S. Securities and Exchange Commission.